朝聚眼科医疗控股有限公司（02219）于2025年12月12日公布翌日披露报表。公告显示，公司于2025年12月11日在香港联交所回购12万股，占回购授权通过当日已发行股本（不含库藏股）总数约0.169%，每股价格区间介乎每股2.63港元至2.70港元，合计支出约32.03万港元。
本次回购后，公司已累计回购股份120万股，占回购授权通过当日已发行股本（不含库藏股）总数的0.169%。该回购授权于2025年6月6日获股东批准，授权数量为7075.105万股。公告称，公司现有已发行股本为707,510,500股，截至披露日期，回购股份尚未注销，且无新增库藏股变动。
公司同时确认已遵守香港联交所相关上市规则和法律规定。公告由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.